Connect your AI

OS Therapies OSTX Chief Operating Decision Maker — Investment Income Interest

Similar metrics at other companies

CHE

CHECInvestment Income Interest

$1.06M—

NVECInvestment Income Interest

$447.43K-6.1%

CEP

CEPOInvestment Income Interest

$1.86M+56.9%

NOEMInvestment Income Interest

$632.15K-12.9%

PZGCorporate — Interest Income Operating

$14.82K+79.8%

NMP

NMPInvestment Income Interest

$1.03M—

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's chief operating decision maker — investment income interest.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's chief operating decision maker — investment income interest?: OS Therapies (OSTX) reported chief operating decision maker — investment income interest of $45 in Q1 2026.
What does chief operating decision maker — investment income interest mean?: Reflects the interest income generated from the company's cash reserves and short-term investments held within the primary operating segment. This metric highlights the return on idle capital that has not yet been deployed into clinical development. It serves as a minor offset to overall operational cash burn.